Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | RAPGEF4 | Q8WZA2 | 2/20 | 0.56 |
| ▸ | GAA | P10253 | 2/20 | 0.52 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.48 |
| ▸ | HTT | P42858 | 2/20 | 0.48 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.48 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.44 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.42 |
| ▸ | LMNA | P02545 | 2/20 | 0.42 |
| ▸ | MEN1 | O00255 | 1/20 | 0.42 |
| ▸ | HCRTR1 | O43613 | 1/20 | 0.42 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.42 |
| ▸ | HDAC3 | O15379 | 1/20 | 0.42 |
| ▸ | HDAC4 | P56524 | 1/20 | 0.42 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.42 |
| ▸ | HDAC7 | Q8WUI4 | 1/20 | 0.42 |
| ▸ | HDAC2 | Q92769 | 1/20 | 0.42 |
| ▸ | HDAC10 | Q969S8 | 1/20 | 0.42 |
| ▸ | HDAC11 | Q96DB2 | 1/20 | 0.42 |
| ▸ | HDAC8 | Q9BY41 | 1/20 | 0.42 |
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL2858487 | 0.97 | RAPGEF4 (0.54) | RAPGEF4GAAALDH1A1HTTKDM4E | |
| SCHEMBL29196035 | 0.81 | RAPGEF4 (0.71) | RAPGEF4GAAALDH1A1HTTKDM4E | |
| SCHEMBL12889181 | 0.81 | HPGD (0.45) | RAPGEF4GAAALDH1A1HTTKDM4E | |
| SCHEMBL9224102 | 0.81 | GAA (0.65) | RAPGEF4GAAALDH1A1HTTKDM4E | |
| SCHEMBL1549143 | 0.79 | RAPGEF4 (0.58) | RAPGEF4GAAALDH1A1HTTTDP1 | |
| SCHEMBL10882869 | 0.77 | GAA (0.55) | RAPGEF4GAAALDH1A1HTTKDM4E | |
| SCHEMBL2092830 | 0.77 | RAPGEF4 (0.54) | RAPGEF4GAAALDH1A1HTTKDM4E | |
| SCHEMBL1485842 | 0.77 | MAPT (0.47) | RAPGEF4GAAALDH1A1HTTNPSR1 | |
| Hydrochloric Acid SCHEMBL2863950 | 0.77 | RAPGEF4 (0.56) | RAPGEF4GAAALDH1A1HTTTDP1 | |
| SCHEMBL12451042 | 0.77 | GAA (0.55) | RAPGEF4GAAALDH1A1HTTKDM4E |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 84 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-114709420-B | Modified polyimide secondary battery adhesive and preparation method thereof | 江苏环峰电工材料有限公司 | 2023-11-14 | — | — | CN | claimed |
| EP-4676924-A1 | CYCLIC NITROGEN COMPOUNDS FOR ORGANIC ELECTROLUMINESCENT DEVICES | Merck Patent GmbH (DE) | 2026-01-14 | — | — | EP | disclosed |
| WO-2025224262-A1 | COMBINATION THERAPIES COMPRISING A CDK2 DEGRADER AND A CDK4/6 INHIBITOR | MONTE ROSA THERAPEUTICS AG (CH) | 2025-10-30 | — | — | WO | disclosed |
| EP-4608816-A1 | COMPOUNDS THAT MEDIATE PROTEIN DEGRADATION AND METHODS OF USE THEREOF | Monte Rosa Therapeutics AG (CH) | 2025-09-03 | — | — | EP | disclosed |
| US-20250263395-A1 | COMPOUNDS THAT MEDIATE PROTEIN DEGRADATION AND METHODS OF USE THEREOF | MONTE ROSA THERAPEUTICS AG (CH) | 2025-08-21 | — | — | US | disclosed |
| WO-2024184050-A1 | CYCLIC NITROGEN COMPOUNDS FOR ORGANIC ELECTROLUMINESCENT DEVICES | MERCK PATENT GMBH (DE) | 2024-09-12 | — | — | WO | disclosed |
| WO-2024148308-A1 | NOVEL, REVERSIBLE DPP1 INHIBITORS AND USES THEREOF | INSMED INCORPORATED (US) | 2024-07-11 | — | — | WO | disclosed |
| WO-2024118607-A1 | COMPOUNDS, COMPOSITIONS, AND METHODS | CHDI FOUNDATION, INC. (US) | 2024-06-06 | — | — | WO | disclosed |
| WO-2024092039-A1 | COMPOUNDS THAT MEDIATE PROTEIN DEGRADATION AND METHODS OF USE THEREOF | MONTE ROSA THERAPEUTICS, INC. (US) | 2024-05-02 | — | — | WO | disclosed |
| CN-114709420-B | Modified polyimide secondary battery adhesive and preparation method thereof | 江苏环峰电工材料有限公司 | 2023-11-14 | — | — | CN | disclosed |
| US-4605766-A | REACTING AROMATIC AMINES WITH ETHERS IN PRESENCE OF CATALYST CONTAINING IRON OXIDE | ETHYL CORPORATION (US) | 1986-08-12 | — | — | US | disclosed |
| US-4599449-A | POSSIBLE RECOVERY OF UNUSED ALCOHOL | ETHYL CORPORATION (US) | 1986-07-08 | — | — | US | disclosed |
| EP-0073277-B1 | PROCESS FOR PRODUCING ORTHOALKYLATED AROMATIC AMINES | MITSUI PETROCHEMICAL INDUSTRIES, LTD. (JP) | 1985-07-17 | — | — | EP | disclosed |
| EP-0148009-A2 | Process for the alkylation of aromatic amines and use of the products thereof | ETHYL CORPORATION (US) | 1985-07-10 | — | — | EP | disclosed |
| EP-0073277-A1 | Process for producing orthoalkylated aromatic amines | MITSUI PETROCHEMICAL INDUSTRIES, LTD. (JP) | 1983-03-09 | — | — | EP | disclosed |
| US-4351958-A | Process for producing orthoalkylated aromatic amine | MITSUI PETROCHEMICAL INDUSTRIES, LTD. (JP) | 1982-09-28 | — | — | US | disclosed |
| US-4172944-A | Water insoluble styryl dyestuffs having hetero-aryl methylene substituent | BAYER AKTIENGESELLSCHAFT (DE) | 1979-10-30 | — | — | US | disclosed |
| US-4115413-A | ACID FREE | BAYER AKTIENGESELLSCHAFT (DE) | 1978-09-19 | — | — | US | disclosed |
| US-4046771-A | GREENISH-YELLOW SHADES ON SYNTHETIC FIBERS | BAYER AKTIENGESELLSCHAFT (DT) | 1977-09-06 | — | — | US | disclosed |
| US-4016191-A | WATER INSOLUBLE; LIGHTFASTNESS | BAYER AKTIENGESELLSCHAFT (DT) | 1977-04-05 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250263395-A1 | COMPOUNDS THAT MEDIATE PROTEIN DEGRADATION AND METHODS OF USE THEREOF | CDK2, SKP2, CDK1 | RAPGEF4 2233/4885GAA 2291/4885ALDH1A1 3818/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.